Zoledronic Acid Injection
Product Images NDC 16729-242

4 FDA label images from Accord Healthcare Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Zoledronic Acid (NDC 16729-242). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Accord Healthcare Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Zoledronic Acid 4mg/5ml Vial Label (Zoledronic Acid Carton)

Zoledronic Acid 4mg/5ml Vial Label (Zoledronic Acid Carton)
Packaging label for Zoledronic acid Injection 4 mg/5 mL (0.8 mg/mL) for intravenous infusion after dilution, by Accord Healthcare Inc. The label states it is a single-dose 5 mL vial, with instructions that the product must be diluted and not mixed with calcium-containing infusion solutions. Storage and preparation details are included, along with the product NDC 16729-242-31.*
FDA Label Image

Zoledronic Acid Structural Formula (Zoledronic Acid Chemical Structure)

Zoledronic Acid Structural Formula (Zoledronic Acid Chemical Structure)
Chemical structure of zoledronic acid showing its molecular framework including imidazole ring and phosphonate groups.*
FDA Label Image

Zoledronic Acid 4mg/5ml Container Label (Zoledronic Acid Container)

Zoledronic Acid 4mg/5ml Container Label (Zoledronic Acid Container)
Label for Zoledronic acid 4 mg/5 mL injection, an intravenous infusion in a 5 mL single-dose vial. Contains dosage strength details (0.8 mg/mL) and usage notes. The product is labeled by Accord Healthcare Inc., with a barcode and NDC 16729-242-31 printed on the label.*
FDA Label Image

Figure 1 Proportion Of Complete Responders By Day 10 In Pooled Hcm Studies (Zoledronic Acid Figure 1)

Figure 1 Proportion Of Complete Responders By Day 10 In Pooled Hcm Studies (Zoledronic Acid Figure 1)
A bar chart titled 'Proportion of Complete Responders by Day 10 in Pooled HCM Studies' comparing the percentage of complete responders between Zoledronic Acid Injection 4 mg and Pamidronate 90 mg. The chart shows higher response rates for Zoledronic Acid Injection compared to Pamidronate, with a statistical significance indicated by P=0.002.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.